ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular disease"

  • Abstract Number: 2563 • 2012 ACR/ARHP Annual Meeting

    Factors Associated with Major Cardiovascular Events in Patients with Primary Systemic Necrotizing Vasculitides: Results of a Longitudinal Long-Term Follow-up Study

    Benjamin Terrier1, Christian Pagnoux2, Gilles Chironi3, Alain Simon3, Luc Mouthon4, Loic Guillevin5 and French Vasculitis Study Group (FVSG)6, 1Internal Medicine, Cochin University Hospital, Paris, France, 2Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, 3HEGP, Paris, France, 4Internal Medicine, Hopital Cochin, Paris, France, 5Internal Medicine, Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, 6Paris

    Background/Purpose: Primary systemic necrotizing vasculitides (SNV) were shown to be associated with more frequent subclinical atherosclerosis, independently of cardiovascular (CV) risk factors and C-reactive protein…
  • Abstract Number: 1443 • 2012 ACR/ARHP Annual Meeting

    Caspase-1 Modulates Endothelial Dysfunction and Vascular Repair in Murine Lupus

    J. Michelle Kahlenberg1, Wenpu Zhao2, Srilakshmi Yalavarthi2 and Mariana J. Kaplan3, 1Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2University of Michigan Rheumatology, Ann Arbor, MI, 3Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD

    Background/Purpose: Premature cardiovascular disease (CVD) represents a significant cause of morbidity and mortality in systemic lupus erythematosus (SLE).  We recently proposed that type I interferon…
  • Abstract Number: 820 • 2012 ACR/ARHP Annual Meeting

    In Rheumatoid Arthritis Incident Fractures Are Associated with an Increased Risk of Cardiovascular Events

    Orla Ni Mhuircheartaigh1, Cynthia S. Crowson2, Sherine E. Gabriel3, Veronique L. Roger4, L. Joseph Melton III5 and Shreyasee Amin6, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, 4Health Sciences Research and Cardiology, Mayo Clinic, Rochester, MN, 5Department of Hlth Sciences, Mayo Clinic, Rochester, MN, 6Health Sciences Research and Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with an increased risk for both fracture (fx) and cardiovascular disease (CVD) and there is increasing evidence establishing a…
  • Abstract Number: 69 • 2012 ACR/ARHP Annual Meeting

    The Presence of Asymptomatic Carotid Plaques in Patients with Inflammatory Joint Disease Results in Inadequate Treatment to Lipid Targets in Cardiovascular Disease Prevention

    Anne G. Semb1, Silvia Rollefstad2, Inge C. Olsen3, Desiree van der Heijde4 and Tore K. Kvien5, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Rhuematology, Diakonhjemmet Hospital, Oslo, Norway, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

     Background/Purpose: The prevalence of asymptomatic carotid plaque (a-CP) is high in patients with inflammatory joint disease (IJD). Patients with a-CP should receive intensive lipid lowering…
  • Abstract Number: 2544 • 2012 ACR/ARHP Annual Meeting

    Widening Gap Between Cardiovascular Specific Mortality in Patients with Inflammatory Polyarthritis Compared to the General Population?

    Alexander J. Warner1, Jh Humphreys2, Mark Lunt3, Tarnya Marshall4, Deborah P. M. Symmons5 and Suzanne Verstappen6, 1Manchester Academic Health Sciences Centre, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 2Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit,, Manchester, United Kingdom, 3Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, 4Rheumatology, Norfolk and Norwich University Hospitals Trust, Norwich, United Kingdom, 5Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 6Arthritis Research UK Epidemiology Unit,, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom

    Background/Purpose: Cardiovascular (CVD) mortality rates are raised in patients with inflammatory polyarthritis (IP) but have been shown to be falling in the general population. This…
  • Abstract Number: 1425 • 2012 ACR/ARHP Annual Meeting

    Circulating Free Protein S Levels May Be Linked to Cardiovascular Events and Venous Thrombosis in SLE

    Gregg J. Silverman1, John Jung2, Ehtisham Akhter3, Michelle Petri4 and Caroline Grönwall2, 1Medical and Pathology, NYU School of Medicine, New York, NY, 2NYU School of Medicine, New York, NY, 3Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 4Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: SLE patients are at risk for diverse organ systems involvement, which increases the challenges for diagnosis and predictions for the development of specific clinical…
  • Abstract Number: 825 • 2012 ACR/ARHP Annual Meeting

    Osteoporosis and Vertebral Fractures Are Important Determinants of Cardiovascular Disease in Rheumatoid Arthritis

    Ausaf Mohammad1, Derek Lohan2, Diane Bergin2, Sarah Mooney2, John Newell3, Martin O'Donnell4, Robert J. Coughlan1 and John J. Carey1, 1Rheumatology, Galway University Hospitals, Galway, Ireland, 2Radiology, Galway University Hospitals, Galway, Ireland, 3Clinical Research Facility, National University of Ireland, Galway, Ireland, 4Clinical Research Facility, Galway University Hospitals, Galway, Ireland

    Background/Purpose: Cardiovascular disease(CVD) represents a major comorbidity and the leading cause of mortality for Rheumatoid arthritis(RA) patients. Unfortunately traditional risk factors for CVD underperform in…
  • Abstract Number: 2688 • 2012 ACR/ARHP Annual Meeting

    The Health Improvement and Prevention Program in Systemic Lupus Erythematosus Demonstrates Improvement in Mental Health and Framingham Risk Score At One Year

    Paul R. Fortin1, Ellie Aghdassi2, Anne Cymet3, Stacey Morrison4, Willy Wynant5, Janet E. Pope6, Sara Hewitt7, Christian A. Pineau8, Carolyn Neville9, Paula Harvey10, Jean-Claude Tardif11, Michal Abrahamowicz12 and Deborah DaCosta13, 1Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada, 2University Health Network Research Institute - Western Division, Toronto, ON, Canada, 3Nursing, University Health Network - Western Division, Toronto, ON, Canada, 4Div Rheumatology Rm MP-10-304, The Toronto Western Hospital, Toronto, ON, Canada, 5Division of Clinical Epidemiology, McGill University Health Centre and McGill University, Montreal, QC, Canada, 6Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 7Rheumatology, St. Joseph's Health Care, University of Western Ontario, London, ON, Canada, 8Rheumatology, McGill University Health Centre, Montreal, QC, Canada, 9Epidemiology, Royal Victoria Hospital, Montreal, QC, Canada, 10Cardiology, Women's College Hospital, Toronto, ON, Canada, 11Montreal Heart Institute, Universite de Montreal endowed research chair in atherosclerosis, Quebec, QC, Canada, 12Clinical Epidemiology, McGill University, Montreal, QC, Canada, 13Montreal General Hospital, Montreal, Canada

    Background/Purpose: The Health Improvement and Prevention Program (HIPP) is a behavioral intervention aimed at improving health status and coping of persons with lupus while reducing…
  • Abstract Number: 2423 • 2012 ACR/ARHP Annual Meeting

    Perceptions Regarding Cardiovascular Risk Factors and Barriers to Risk Reduction Among African American Women with Lupus

    Barron Mia1, Lynne Nemeth1, Diane L. Kamen2 and Youlanda C. Gibbs1, 1College of Nursing, Medical University of South Carolina, Charleston, SC, 2Department of Medicine, Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Charleston, SC

    Background/Purpose: Cardiovascular disease (CVD) is highly prevalent among African American (AA) women diagnosed with systemic lupus erythematosus (SLE). Studies have suggested that CVD risk factors…
  • Abstract Number: 1429 • 2012 ACR/ARHP Annual Meeting

    Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Aorta Calcium (AS) Than Women without SLE

    Apinya Lertratanakul1, Peggy W. Wu2, Alan Dyer1, William Pearce1, George Kondos3, Daniel Edmundowicz4, James Carr5 and Rosalind Ramsey-Goldman6, 1Northwestern University, Chicago, IL, 2Rheumatology, Northwestern University, Chicago, IL, 3University of Illinois at Chicago, Chicago, IL, 4Temple University School of Medicine, Philadelphia, PA, 5Northwestern University Feinberg School of Medicine, Chicago, IL, 6Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Women with SLE have increased rates of subclinical atherosclerosis and cardiovascular (CV) events.  We investigated which risk factors may be significant in the rate…
  • Abstract Number: 827 • 2012 ACR/ARHP Annual Meeting

    Sustained Development of Cardiovascular Disease in Rheumatoid Arthritis Despite Cardioprotective Treatment: The 10-Year Prospective Carre-Study

    Alper M. van Sijl1, Inge A.M. van den Oever1, Mike J.L. Peters2, Vokko P. van Halm3, Alexandre E. Voskuyl4, Yvo M. Smulders5 and Mike T. Nurmohamed1, 1Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 2Internal medicine, VU University Medical Center, Amsterdam, Netherlands, 3Cardiology, Academic Medical Centre, Amsterdam, Netherlands, 4Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 5Internal Medicine, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease which is associated with an increased cardiovascular (CV) risk. It is still unknown to what…
  • Abstract Number: 2685 • 2012 ACR/ARHP Annual Meeting

    Overall and Cause Specific Mortality in Patients with Systemic Lupus Erythematosus. A Meta-Analysis of Observational Studies

    Marko Yurkovich1, Kateryna Vostretsova2 and J. Antonio Avina-Zubieta3, 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada

    Background/Purpose:  Systemic lupus erythematosus (SLE), is a chronic autoimmune condition. It has the potential to affect any organ system and can be associated with severe…
  • Abstract Number: 2263 • 2012 ACR/ARHP Annual Meeting

    The Association Between Prior Pregnancy Morbidity and Cardiovascular Events in Women with Systemic Lupus Erythematosus

    Megan E. B. Clowse1, Eliza F. Chakarvarty2, Jill P. Buyon3 and Gerald McGwin Jr.4, 1Rheumatology, Duke University Medical Center, Durham, NC, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, CA, 3Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Adverse pregnancy outcomes have been associated with increased cardiovascular disease in healthy women.  We hypothesized that women with SLE and a history of adverse…
  • Abstract Number: 1430 • 2012 ACR/ARHP Annual Meeting

    Women with Systemic Lupus Erythematosus (SLE) May Have Different Predictors of Risk for Progression of Coronary Artery Calcium (CAC)Than Women without SLE

    Apinya Lertratanakul1, Peggy W. Wu2, Alan Dyer1, William Pearce1, George Kondos3, Daniel Edmundowicz4, James Carr5 and Rosalind Ramsey-Goldman6, 1Northwestern University, Chicago, IL, 2Rheumatology, Northwestern University, Chicago, IL, 3University of Illinois at Chicago, Chicago, IL, 4Temple University School of Medicine, Philadelphia, PA, 5Northwestern University Feinberg School of Medicine, Chicago, IL, 6Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

     Background/Purpose: Women with SLE have increased rates of subclinical atherosclerosis and cardiovascular (CV) events.  We sought to determine which risk factors may be significant in…
  • Abstract Number: 716 • 2012 ACR/ARHP Annual Meeting

    Utility of Novel Patient-Reported Outcome Instruments in Predicting Cardiac Involvement and Pulmonary Hypertension in Patients with Systemic Sclerosis

    Monique E. Hinchcliff1, Mary A. Carns2, Sofia Podlusky2, John Varga3 and Sanjiv J. Shah4, 1Northwestern University, Feinberg School of Medicine, Chicago, IL, 2Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Heart involvement in systemic sclerosis (SSc) includes left ventricular systolic and diastolic dysfunction, right ventricular dysfunction, pericardial disease, and pulmonary hypertension. We recently demonstrated…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology